Pomegra
ElevenLabs closed a $300M employee tender at a $22B valuation, co-led by Wellington and T. Rowe Price, and says it is aiming to be IPO-ready by 2028.
Key Takeaways
- ElevenLabs closed a $300M employee tender at $22B, double its $11B Series D mark from February 2026.
- Wellington and T. Rowe Price co-led. EQT, Goldman Sachs, GIC, OTPP, Sapphire Ventures and BDT & MSD joined for the first time.
- CEO Mati Staniszewski wants the company's public-listing "foundation ready" by 2028.
Lead
ElevenLabs, the London-based voice AI company, closed a $300M employee tender offer on September 30, 2026, at a $22B valuation. The price is twice the $11B set in its $500M Series D in February. Wellington and T. Rowe Price, two long-only mutual fund managers, co-led the deal.
A tender is a secondary sale. Employees and existing holders sell shares to incoming investors, so the company does not receive the $300M. The figure measures what buyers will pay for existing stock, not how much cash the company has raised.
Who Bought the Shares?
The buyers are a mix of crossover institutions and existing backers. EQT, Goldman Sachs, GIC, Ontario Teachers' Pension Plan (OTPP), Sapphire Ventures and BDT & MSD Partners invested in ElevenLabs for the first time. Existing investors Andreessen Horowitz, Lightspeed, ICONIQ, D.E. Shaw, Evantic, DISRUPTIVE and Alkeon also took part.
The lead pair matters more than the headline number. Wellington and T. Rowe Price typically hold large positions in listed companies, and their presence on a private cap table is a common step before a listing. Sovereign and pension money from GIC and OTPP points the same way. Venture-style growth rounds rarely draw this buyer set.
Why Did the Valuation Double in Eight Months?
The valuation doubled because the company reports sharp growth in its newer agent product. ElevenLabs says ARR from ElevenAgents, its platform for AI voice agents in customer support, has tripled since February. The platform now handles more than 15 million conversations a week, also triple the February figure.
Enterprise accounts for 55% of revenue. ElevenLabs says its technology is used by 5 of the top 10 tech companies, 5 of the top 10 insurers and 4 of the top 10 telecoms. It also says voice agents resolve issues 31% faster than chat agents on average. These are company-reported figures, and the company has not disclosed total ARR for 2026. It closed 2025 with more than $330M in ARR, per its Series D announcement.
A skeptical read is available. A tender sets a price through a limited volume of trades, and $300M against a $22B valuation is 1.4% of the company. Small secondary sales can clear at high prices when demand is strong and supply is controlled. Still, buying at $22B means these investors accept a revenue multiple that depends on the agent business continuing to compound.
What Does This Say About the Last Round?
The Series D at $11B, led by Sequoia, now looks cheap. That round was itself more than triple the valuation a year earlier. A September 2025 employee tender of $100M, led by Sequoia and ICONIQ, priced the company at $6.6B. In just over a year, the price per share implied by three transactions has more than tripled.
Total primary funding stood at $781M across five rounds after the Series D. The tender adds no money to that figure. Employees, who now number more than 800, gain a second liquidity event in about a year. The company says it intends to keep offering regular opportunities.
What Comes Next: Is an IPO Realistic?
An IPO is the stated goal, but not yet scheduled. Staniszewski has said the company would like to be ready "in the next couple of years" and that "by 2028, I think we should hopefully have the foundation ready." That is a statement about readiness, not a filing date.
Several variables will shape the timing. Public investors will want audited revenue, margin detail and evidence that agent revenue is recurring rather than pilot-driven. Competition is another test: large cloud providers and model labs offer their own speech and voice-agent tools, which can pressure pricing. Public-market appetite for AI listings in 2028 is also unknowable today.
The institutional buyers in this tender would be natural anchor holders in a listing. Their entry price of $22B also sets a reference point. A listing below it would embarrass them, so the valuation now carries expectations that growth must meet.
Outlook
ElevenLabs has doubled its valuation in eight months, brought in the kind of long-only and sovereign investors that usually precede a public offering, and given staff a second payout. The next evidence will be disclosed revenue and whether ElevenAgents growth holds after tripling in six months. A 2028 listing is a target for readiness, and the $22B price gives future public investors a high bar to clear.
